Transplantation of retrovirus-transduced canine keratinocytes expressing the beta-galactosidase gene
- PMID: 7584097
Transplantation of retrovirus-transduced canine keratinocytes expressing the beta-galactosidase gene
Abstract
We studied transplantation of retrovirus vector transduced canine keratinocytes to determine whether keratinocytes could persist and express the transferred gene after superficial transplantation to full-thickness wounds of dogs, a large random-bred model for gene transfer studies. Canine keratinocytes were transduced by co-cultivation with PA317 retrovirus packaging cells which produced helper-free amphotropic retroviral vectors (LZSN and LNPOZ) encoding the genes for beta-galactosidase (beta-gal) and neomycin phosphotransferase (neo). Efficient transfer and expression of the two genes could be demonstrated in confluent keratinocyte cultures for both vectors. When transduced keratinocytes were grown in organotypic cultures on a collagen matrix containing autologous dermal fibroblasts at the air-liquid interface, the cultures showed well-organized and defined epidermal cell layers and several markers of terminal differentiation, including the presence of keratohyalin granules and a multilayered stratum corneum. To determine whether the transferred beta-gal gene was also expressed in vivo, we performed autologous transplantation of transduced keratinocytes onto full-thickness wounds of dogs. beta-Gal expressing keratinocytes could be demonstrated in situ in the regenerating epidermis 2 weeks after transplantation. We conclude that keratinocytes can be efficiently transduced by retroviral vectors, that retroviral transduction does not interfere with proliferation or differentiation, and that transduced keratinocytes express the transferred gene after transplantation to full-thickness skin wounds of dogs. Keratinocytes thus seem to be good target cells for gene therapy.
Similar articles
-
A large preclinical animal model to assess ex vivo skin gene therapy applications.Arch Dermatol Res. 2006 Jun;298(1):16-22. doi: 10.1007/s00403-006-0653-5. Epub 2006 Mar 25. Arch Dermatol Res. 2006. PMID: 16565820
-
Use of bicistronic retroviral vectors encoding the LacZ gene together with a gene of interest: a method to select producer cells and follow transduced target cells.Cancer Gene Ther. 1996 Sep-Oct;3(5):345-51. Cancer Gene Ther. 1996. PMID: 8894254
-
Myeloproliferative sarcoma virus directed expression of beta-galactosidase following retroviral transduction of murine hematopoietic cells.Exp Hematol. 1995 Jul;23(7):630-8. Exp Hematol. 1995. PMID: 7601255
-
Retrovirus vector-mediated gene transfer into hepatocytes.Mol Biol Med. 1989 Apr;6(2):117-25. Mol Biol Med. 1989. PMID: 2693887 Review.
-
High-level secretion of growth hormone by retrovirally transduced primary human keratinocytes: prospects for an animal model of cutaneous gene therapy.Mol Biotechnol. 2006 Oct;34(2):239-45. doi: 10.1385/mb:34:2:239. Mol Biotechnol. 2006. PMID: 17172669 Review.
Cited by
-
PTD-mediated loading of tumor-seeking lymphocytes with prodrug-activating enzymes.AAPS J. 2008 Dec;10(4):614-21. doi: 10.1208/s12248-008-9066-z. Epub 2008 Dec 23. AAPS J. 2008. PMID: 19104945 Free PMC article.
-
Immune-mediated loss of transgene expression in skin: implications for cutaneous gene therapy.Mol Ther. 2003 Mar;7(3):296-303. doi: 10.1016/s1525-0016(03)00013-3. Mol Ther. 2003. PMID: 12668125 Free PMC article.
-
Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy.J Virol. 1997 Dec;71(12):9163-9. doi: 10.1128/JVI.71.12.9163-9169.1997. J Virol. 1997. PMID: 9371574 Free PMC article.
-
In vivo assessment of gene delivery to keratinocytes by lentiviral vectors.J Virol. 2002 Feb;76(3):1496-504. doi: 10.1128/jvi.76.3.1496-1504.2002. J Virol. 2002. PMID: 11773422 Free PMC article.
-
Clonal analysis of stably transduced human epidermal stem cells in culture.Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10371-6. doi: 10.1073/pnas.93.19.10371. Proc Natl Acad Sci U S A. 1996. PMID: 8816807 Free PMC article.